Sodium Iodide → tert-butyl(S)-1-((3S,4S)-1-((2-chloro-3-methylquinolin-4-yl)methyl)-4-methyl-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate

HRID 1486055Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1486055
[Cl:1][C:2]1[C:11]([CH3:12])=[C:10]([CH2:13]O)[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[N:3]=1.C(N(CC)CC)C.CS(Cl)(=O)=O.[CH3:27][N:28]([C@@H:36]([CH3:60])[C:37]([NH:39][C@H:40]1[C@H:46]([CH3:47])[N:45]([C:48](=[O:54])[CH2:49][S:50]([CH3:53])(=[O:52])=[O:51])[C:44]2[CH:55]=[CH:56][CH:57]=[CH:58][C:43]=2[NH:42][C:41]1=[O:59])=[O:38])[C:29](=[O:35])[O:30][C:31]([CH3:34])([CH3:33])[CH3:32].C(=O)([O-])[O-].[Cs+].[Cs+].[I-].[Na+]>C(Cl)Cl.CN(C=O)C.CCOC(C)=O>[Cl:1][C:2]1[C:11]([CH3:12])=[C:10]([CH2:13][N:42]2[C:41](=[O:59])[C@@H:40]([NH:39][C:37](=[O:38])[C@@H:36]([N:28]([CH3:27])[C:29](=[O:35])[O:30][C:31]([CH3:34])([CH3:32])[CH3:33])[CH3:60])[C@H:46]([CH3:47])[N:45]([C:48](=[O:54])[CH2:49][S:50]([CH3:53])(=[O:52])=[O:51])[C:44]3[CH:55]=[CH:56][CH:57]=[CH:58][C:43]2=3)[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[N:3]=1

Komponenten

10

Versuchsvorschrift

To a rt suspension of (2-chloro-3-methylquinolin-4-yl)methanol (61 mg, 294 μmol) in CH2Cl2 (2.94 ml) was added triethylamine (81.9 μl, 588 μmol), followed by methanesulfonyl chloride (27.3 μl, 353 μmol), dropwise. The reaction was stirred at rt for 1.5 h, then diluted with CH2Cl2, washed with H2O and sat. aq. NaCl, dried over Na2SO4, filtered, and concentrated. This material was mixed with tert-butyl methyl((S)-1-((2S,3S)-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl)carbamate (100 mg, 201 μmol), cesium carbonate (85.3 mg, 262 μmol), and sodium iodide (39.2 mg, 262 μmol) in DMF (503 μl). The reaction was stirred at rt for 16 h, then diluted with EtOAc, washed with H2O and sat. aq. NaCl, dried over Na2SO4, filtered, and concentrated. The crude material was purified by flash chromatography to provide tert-butyl(S)-1-((3S,4S)-1-((2-chloro-3-methylquinolin-4-yl)methyl)-4-methyl-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (62.6 mg, 45%) as a white solid. MS m/z 708 (MNa)+.

Aufarbeitung

  1. washwashed with H2O and sat. aq. NaCl
  2. dry with materialdried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated
  5. stirringThe reaction was stirred at rt for 16 h
  6. washwashed with H2O and sat. aq. NaCl
  7. dry with materialdried over Na2SO4
  8. filtrationfiltered
  9. concentrationconcentrated
  10. customThe crude material was purified by flash chromatography

Quellen und Nachweise

ORD-Eintrag
ord-18acdcd93776476ab207ced07b242373
Quelldatensatz
uspto-grants-2016_08
Patentnummer
US09422331B2

Notizen zur Reaktion

Wird geladen…